Recipharm Advanced Bio Capabilities Update March 2026: Analytical Services

In this session, attendees will gain insight into how a comprehensive analytical service portfolio can be strategically leveraged to provide true end‑to‑end support across release testing, stability studies, and product characterization for a wide range of therapeutic modalities. The presentation will outline how an integrated analytical framework strengthens development programs by aligning scientific rigor with operational efficiency.

A key focus will be the lifecycle‑based approach that seamlessly connects method development, phase‑appropriate qualification, validation, and routine testing. Speakers will demonstrate how this cohesive structure reduces analytical variability, accelerates timelines, and enhances readiness for regulatory submissions. Case examples will illustrate how coordinated analytical strategies de‑risk development and support smooth transitions from early research through clinical and commercial stages.

Participants will leave with a clearer understanding of how holistic analytical planning and tightly integrated workflows can drive consistency, compliance, and long‑term success in complex biologics and advanced therapy programs.